Min Ki Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Min Ki Lee has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Ae Sol Lee
Department of Chemical & Biochemical Engineering, Dongguk University, Seoul 04620, Republic of Korea
1 shared publication - Chang Sup Kim
Department of Chemical and Biochemical Engineering, Dongguk University, Seoul, Republic of Korea
1 shared publication Danishmalik Rafiq Sayyed
Precision Biosensor, 306, Techno 2-ro, Yuseong-gu, Daejeon 34036, South Korea
1 shared publicationEunhee Han
Department of Laboratory Medicine, Daejeon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea
1 shared publicationHanshin Kim
Precision Biosensor, 306, Techno 2-ro, Yuseong-gu, Daejeon 34036, South Korea
1 shared publicationHye Won Kang
Precision Biosensor, 306, Techno 2-ro, Yuseong-gu, Daejeon 34036, South Korea
1 shared publication
Latest Publications
- Open Access
- 27 November 2025
- Published by MDPI AG in Biomimetics
- Vol. 10 (12) , 798
Core–Shell Silk Fibroin Hydrogel Microneedles Functionalized with Antibody-Binding Domains for Transdermal Delivery
Microneedle (MN) patches comprise a promising platform for transdermal delivery of macromolecular therapeutics. However, achieving sufficient mechanical strength for skin penetration while maintaining high biocompatibility and efficient antibody loading remains a major challenge. In this study, we designed and developed a core–shell-structured hydrogel MN patch composed of a silk fibroin core and a protein-based shell layer for antibody loading and potential transdermal release. The latter was constructed using a fusion protein consisting of the B and C domains of Staphylococcus aureus protein A (BC) and a tyrosine-rich mussel adhesive protein (MAP), thereby enabling antibody binding via the BC domains. By harnessing biomimetic design strategies, the BC-MAP shell facilitates antibody immobilization via specific affinity interactions, while the silk fibroin core provides substantial mechanical strength: the MN patch demonstrated a penetration force approximately 4.2 times greater than that required to pierce porcine skin. Collectively, our core–shell-structured hydrogel MN patch is a promising platform for transdermal antibody delivery.
- 27 November 2025
- Published by MDPI AG in Biomimetics
- Vol. 10 (12) , 798
Open AccessCore–Shell Silk Fibroin Hydrogel Microneedles Functionalized with Antibody-Binding Domains for Transdermal Delivery
Microneedle (MN) patches comprise a promising platform for transdermal delivery of macromolecular therapeutics. However, achieving sufficient mechanical strength for skin penetration while maintaining high biocompatibility and efficient antibody loading remains a major challenge. In this study, we designed and developed a core–shell-structured hydrogel MN patch composed of a silk fibroin core and a protein-based shell layer for antibody loading and potential transdermal release. The latter was constructed using a fusion protein consisting of the B and C domains of Staphylococcus aureus protein A (BC) and a tyrosine-rich mussel adhesive protein (MAP), thereby enabling antibody binding via the BC domains. By harnessing biomimetic design strategies, the BC-MAP shell facilitates antibody immobilization via specific affinity interactions, while the silk fibroin core provides substantial mechanical strength: the MN patch demonstrated a penetration force approximately 4.2 times greater than that required to pierce porcine skin. Collectively, our core–shell-structured hydrogel MN patch is a promising platform for transdermal antibody delivery.
- 11 March 2024
- Published by Elsevier in Clinica Chimica Acta
- Vol. 557, 117872
A comprehensive Exdia TRF-LFIA for simultaneous quantification of GFAP and NT-proBNP in distinguishing ischemic and hemorrhagic stroke
- 11 March 2024
- Published by Elsevier in Clinica Chimica Acta
- Vol. 557, 117872
A comprehensive Exdia TRF-LFIA for simultaneous quantification of GFAP and NT-proBNP in distinguishing ischemic and hemorrhagic stroke